adplus-dvertising
Connect with us

Business

Moderna facility in Montreal area expected to produce 100 million vaccine doses by 2024 – CBC.ca

Published

 on


The American pharmaceutical giant Moderna confirmed Friday that it has chosen the greater Montreal area as the location for its new biomanufacturing plant — the company’s first outside of the United States.

The $180-million facility is expected to produce 100 million doses of mRNA vaccines per year. 

“It’s important to have manufacturing in Canada,” said Prime Minister Justin Trudeau at McGill University, standing alongside Moderna CEO Stéphane Bancel and Quebec Premier François Legault.

“We are strengthening our own ability to respond to viruses.”

Details on its precise location are still pending. Minister of Innovation, Science and Industry François-Philippe Champagne, who was also present, said the company is still in the process of shopping around for potential sites. 

Construction for the plant will begin sometime this year and is expected to be completed by 2024.

Legault said the plant will better prepare the province for future pandemics by reinforcing domestic supply chains and vaccine autonomy.  

“We’ve had a hard two years,” he said. “We’ve had to look for masks, medical gowns, and then vaccines. We have learned we are better served by ourselves.”

Canada’s biomanufacturing industry has declined, Legault acknowledged, but what remains is centred in Quebec and the Greater Toronto Area, both of whom were in the running for the plant. 

“Today I’m pleased to announce that Quebec has won the battle for the Moderna facility.”

The facility will also include a research centre that will work in collaboration with researchers from McGill University, who have signed a partnership with the company, and will have the capacity to produce mRNA vaccines against other respiratory viruses including the seasonal flu. Funding for that research is expected to come from Moderna. 

“For the first time in the history of medicine, we have a molecule that is an information molecule and that changes everything. It’s like going from Blockbuster to Netflix — it’s a change of paradigm,” said Bancel. 

The company has signed a 10-year partnership with the federal government to operate the facility, he said. 

WATCH | Justin Trudeau announces new Moderna plant in Quebec:

Justin Trudeau announces new Moderna plant in Quebec

14 hours ago

Duration 1:09

The American pharmaceutical giant Moderna’s first plant outside of the U.S. will be located in the Montreal area. 1:09

“The government of Canada was one of our first global partners in the very early days of COVID,” Bancel added. “When I was raising money in 2020, we did not have the financial strength to get this industrial machine going, and Canada was one of the few countries here to help.”

Details of the agreement between Moderna and the Quebec and Canadian governments weren’t released. It’s still unclear how much public money will go toward financing the $180-million facility.

Moderna signed an agreement of understanding with the federal government last August to bring such a factory to Canada.  A federal government news release on Friday said the parties were still working out the details of the deal.

Moderna leading vaccine inequality, critics say

The advocacy group the Council of Canadians has condemned the partnership, saying it will only deepen global vaccine inequality. 

“We’re rolling out the red carpet for a company that has been an architect of a massively unequal distribution of vaccines doses around the world. So unequal that the World Health Organization has called it vaccine apartheid,” said Nikolas Barry Shaw, the trade and privatization campaigner with the council. 

Champagne told reporters Friday the government hopes Canada will retain preferential treatment for the vaccines produced at the facility. 

“If Moderna is gonna be manufacturing vaccines in Canada, Canadians will be first in line.”

Until COVID-19 vaccines are widely available in low-income countries, the virus and new variants will continue to spread, Barry Shaw said. 

“We think we should be spending public money on building public manufacturing capacity and sharing the technology,” he said, adding countries at the World Trade Organization have been calling on giants like Moderna and Pfizer to lift the patents on vaccines. 

WATCH | Moderna executive says local presence could mean smoother future vaccine rollouts:

Moderna rep says Canadian plant would put the country in a better position for future pandemics

10 hours ago

Duration 6:03

Moderna’s general manager in Canada Patricia Gauthier says having a manufacturing plant here would prevent delays in vaccine rollouts in the event of another pandemic. 6:03

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending